ARWR 241220 25.00P (ARWR241220P25000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ARWR241220P25000

Watchlist

1.80
-4.60-71.88%

15min DelayClose Nov 27 16:00 ET

3.00High1.30Low

Intraday

5D
Daily

News

Analysts' Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR) and Sanofi (OtherSNYNF)
TipRanks22:20 ET · Ratings
Arrowhead Pharmaceuticals Faces Distribution Risks With Vanscoy Reliance
TipRanksNov 28 01:00 ET
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
BenzingaNov 27 13:10 ET
SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies
Zacks Nov 27 11:00 ET
Arrowhead Pharmaceuticals Is Maintained at Neutral by Citigroup
Dow JonesNov 27 10:34 ET · Ratings
Express News | Arrowhead Pharmaceuticals Shares up 6.2% ; at Least Two Brokerages Raise PT After Licensing Deal With Sarepta
ReutersNov 27 09:36 ET

Comments

Andrew Whiteside

Nov 22 09:29

$Arrowhead Pharmaceuticals (ARWR.US)$ $50

stockhub

Apr 7 11:23

Hope price action is consistent with result

Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertriglyceridemia
$Arrowhead Pharmaceuticals (ARWR.US)$

Mooers' Insights

Tonyco

Apr 6 22:01

$Arrowhead Pharmaceuticals (ARWR.US)$
Insiderd selling shares and financials dont look good. Im guessing they dont have anything in the pipeline?

Moomoo AI

Mar 8 05:54

The company's poor performance and the CEO's high pay, despite falling earnings and shareholder value, may upset shareholders. The upcoming AGM on March 14th is a chance for shareholders to hold the board and management accountable.

We Think Shareholders May Want To Consider A Review Of Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) CEO Compensation Package

zulia3003

Mar 7 11:34

$Arrowhead Pharmaceuticals (ARWR.US)$ why drop today?